Nathan D. Mathewson
2Patents
1h-index
6Co-inventors
30Inventor score
Filing activity: Nov 13, 2018 → Aug 24, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11459389B2 | Monoclonal antibodies that bind human CD161 | Chemistry; Metallurgy | 2 | Active |
| US12018080B2 | Methods and compositions for treating cancer by targeting the CLEC2D-KLRB1 pathway | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.